Anaesthetic Management During High-Intensity Focused Ultrasound for Uterine Fibroids and Adenomyosis: A Narrative Review.

Samantha Govender; Harshal J Mistry

doi:10.51168/ca520z37

Authors

Dr. Samantha Govender MBChB (UCT), DA (SA), Medical Officer, Chris Hani Baragwanath Academic Hospital
Dr. Harshal J Mistry MBBCh (Wits), DA(SA), Anaesthetic Registrar, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand.

DOI:

https://doi.org/10.51168/ca520z37

Keywords:

High-Intensity focused ultrasound, Uterine Fibroids, Adenomyosis, Anaesthesia, Sedation, Analgesia, Regional Anaesthesia, Patient safety

Abstract

Abstract

High-intensity focused ultrasound (HIFU) is a non-invasive treatment option for uterine fibroids and adenomyosis. The procedure requires prolonged patient immobility while maintaining adequate analgesia and, where possible, communication with the operator. The choice of anaesthetic technique is therefore important, but evidence regarding optimal anaesthetic management remains limited. This narrative review aimed to identify and compare anaesthetic and analgesic techniques used during HIFU treatment of uterine fibroids and adenomyosis, with consideration of their efficacy, safety and reported clinical outcomes. An electronic literature search was conducted using PubMed, MEDLINE, Google Scholar and the Cochrane Library. Studies were included if they reported an anaesthetic or analgesic technique used during HIFU for uterine fibroids or adenomyosis and described relevant outcomes or adverse effects. The available evidence included systemic analgesia, conscious sedation, regional anaesthesia and general anaesthesia. Systemic analgesia alone appeared insufficient to provide consistent pain relief. Opioid and sedative combinations allowed communication but ongoing pain was reported in several studies. Dexmedetomidine-remifentanil was associated with less respiratory depression, improved sedation and recovery compared with midazolam-remifentanil in one randomised controlled trial. Regional techniques, particularly epidural anaesthesia, provided effective analgesia and reduced opioid requirements, although rescue analgesia and neuraxial complications were reported. General anaesthesia was less frequently described and may limit communication during treatment. Overall, the evidence was heterogeneous, with inconsistent reporting of pain, sedation, patient satisfaction and adverse outcomes. Current evidence does not establish the superiority of any one anaesthetic technique. Future prospective studies should directly compare techniques using standardised measures of pain, sedation, patient comfort, respiratory and cardiovascular safety, rescue analgesia, and treatment-related outcomes. Such evidence may help guide anaesthetic practice and improve the safety and patient experience of HIFU treatment.

Author Biographies

Dr. Samantha Govender, MBChB (UCT), DA (SA), Medical Officer, Chris Hani Baragwanath Academic Hospital

MBChB (UCT), DA (SA), Medical officer, Chris Hani Baragwanath Academic Hospital
Dr. Harshal J Mistry, MBBCh (Wits), DA(SA), Anaesthetic Registrar, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand.

MBBCh(Wits), DA(SA), Anaesthetic Registrar, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand.

References

1. Verpalen IM, van 't Veer-ten Kate M, de Boer E, et al. Development and clinical evaluation of a 3-step modified manipulation protocol for MRI-guided high-intensity focused ultrasound of uterine fibroids. Eur Radiol. 2020;30:3869-78. https://doi.org/10.1007/s00330-020-06780-2

2. Yao CL, Trinh T, Wong GT, Irwin MG. Anaesthesia for high-intensity focused ultrasound (HIFU) therapy. Anaesthesia. 2008;63:865-72. https://doi.org/10.1111/j.1365-2044.2008.05562.x

3. Hans GA, Sottiaux TM, Lamy ML, Joris JL. Ventilatory management during routine general anaesthesia. Eur J Anaesthesiol. 2009;26(1):1-8. https://doi.org/10.1097/EJA.0b000e000000f1fb

4. Lee CS, Lee JY, Ro S, Choi S, Moon JY. Comparison of effectiveness of epidural analgesia and monitored anesthesia care for high-intensity focused ultrasound treatment of adenomyosis. Int J Hyperthermia. 2018;35:617-25. https://doi.org/10.1080/02656736.2018.1516300

5. Buttram VC Jr, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981;36:433-45. https://doi.org/10.1016/S0015-0282(16)45789-4

6. Consoli RJ, Carlson K. Adenomyosis. [Updated 2026 Jun 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539868/

7. Dubinsky TJ, Cuevas C, Dighe MK, Kolokythas O, Hwang JH. High-intensity focused ultrasound: current potential and oncologic applications. Am J Roentgenol. 2008;190:191-9. https://doi.org/10.2214/AJR.07.2671

8. Izadifar Z, Izadifar Z, Chapman D, Babyn P. An introduction to high-intensity focused ultrasound: systematic review on principles, devices, and clinical applications. J Clin Med. 2020;9:460. https://doi.org/10.3390/jcm9020460

9. Leung JHY, Yu SCH, Cheung ECW, Wong ASW, Tong MMB, Ho SSY, et al. Safety and efficacy of sonographically guided high-intensity focused ultrasound for symptomatic uterine fibroids. J Ultrasound Med. 2014;33:1811-8. https://doi.org/10.7863/ultra.33.10.1811

10. Liao D, Xiao Z, Lv F, Chen J, Qiu L. Non-contrast enhanced MRI for assessment of uterine fibroids' early response to ultrasound-guided high-intensity focused ultrasound thermal ablation. Eur J Radiol. 2020;122:108670. https://doi.org/10.1016/j.ejrad.2019.108670

11. Chen J, Chen W, Zhang L, Li K, Peng S, He M, et al. Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: a review of 9988 cases. Ultrason Sonochem. 2015;27:671-6. https://doi.org/10.1016/j.ultsonch.2015.05.031

12. Gong C, Wang Y, Lv F, Zhang L, Wang Z. Evaluation of high-intensity focused ultrasound treatment for different types of adenomyosis based on magnetic resonance imaging classification. Int J Hyperthermia. 2022;39:530-8. https://doi.org/10.1080/02656736.2022.2052366

13. Fu X, Huang F, Chen Y, Deng Y, Wang Z. Application of dexmedetomidine-remifentanil in high-intensity ultrasound ablation of uterine fibroids: a randomised study. BJOG. 2017;124 Suppl 3:23-9. https://doi.org/10.1111/1471-0528.14740

14. Carroll JJ, Graves HB. Regional anaesthesia. Can Med Assoc J. 1948;59:156-9.

15. Lee JS, Lee KH, Kim TE. Effect of paracervical block before ultrasound-guided high-intensity focused ultrasound treatment in uterine fibroids and adenomyosis. Clin Exp Obstet Gynecol. 2022;49:167. https://doi.org/10.31083/j.ceog4908167

16. Yang S, Zhang Y, Yang F, Luo L. EC50 and EC95 of epidural ropivacaine for intraoperative analgesia during high-intensity focused ultrasound for adenomyosis: a prospective double-blind up-and-down concentration-finding study. Drug Des Devel Ther. 2026;20:594039. https://doi.org/10.2147/DDDT.S594039

17. Vahabi S, Beiranvand S, Kiabi F, Rastad H. The complications after general anesthesia between female and male genders in the first 24 hours after surgery. Open Public Health J. 2024;17:e18749445328813. https://doi.org/10.2174/0118749445328813241001023931

18. Reel B, Maani CV. Dexmedetomidine. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513303/

19. Okello MO, Mung'ayi V, Adam R, Kabugi J. A comparison of risk of hypotension using standard doses of remifentanil versus dexmedetomidine infusions in adult patients undergoing surgery under general anaesthesia at the Aga Khan University Hospital, Nairobi. Afr Health Sci. 2018;18(4):1267-82. https://doi.org/10.4314/ahs.v18i4.48